Evaluation of the Impact of Tocilizumab Use in Recipients of CAR T Cells for Non-Hodgkin Lymphoma

被引：0

作者：

Cassanello, Giulio ^{[1
,2
]}

Luttwak, Efrat ^{[3
]}

Devlin, Sean M. ^{[4
]}

De Abia, Alejandro Luna ^{[1
]}

Corona, Magdalena ^{[1
]}

Landego, Ivan ^{[1
]}

Parascondola, Allison ^{[1
]}

Saldia, Amethyst ^{[1
]}

Alarcon Tomas, Ana ^{[1
,5
]}

Dahi, Parastoo B. ^{[1
]}

Lin, Richard J. ^{[1
]}

Palomba, M. Lia ^{[3
]}

Park, Jae H. ^{[6
]}

Salles, Gilles ^{[3
]}

Perales, Miguel-Angel ^{[1
]}

Scordo, Michael ^{[1
]}

Shouval, Roni ^{[1
]}

Shah, Gunjan L. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[2] Univ Milan, Milan, Italy

[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY USA

[5] Hosp Gen Univ Gregorio Maranon, Div Hematol & Hemotherapy, Madrid, Spain

[6] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190500

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Evaluation of CD70 Chimeric Antigen Receptor T (CAR-T) Cells As a Potential Treatment for Non-Hodgkin's Lymphoma: A Preclinical Study
Jiang, Pengfei
Xiong, Qinghui
Yuan, Xiujie
Zhang, Haoyu
Shen, Qiushuang
Wang, Yang
Gong, Yiwei
BLOOD, 2023, 142
[32] Non-Hodgkin lymphoma
Armitage, James O.
Gascoyne, Randy D.
Lunning, Matthew A.
Cavalli, Franco
LANCET, 2017, 390 (10091): : 298 - 310
[33] Non-Hodgkin lymphoma
Shankland, Kate R.
Armitage, James O.
Hancock, Barry W.
LANCET, 2012, 380 (9844): : 848 - 857
[34] Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL)
Habib, Alma
Welkie, Rina
Butman, Jacob
Silberman, Pedro C.
Forero, Jose Vicente
Sawalha, Yazeed
Christian, Beth
Maddocks, Kami J.
Epperla, Narendranath
Jaglowski, Samantha Mary
Bond, David Alan
Choe, Hannah Kyung
Brammer, Jonathan Edward
Kittai, Adam
Bezerra, Evandro
Voorhees, Timothy
Vasu, Sumithira
Wall, Sarah Allison
De Lima, Marcos J. G.
Denlinger, Nathan
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[35] Non-Hodgkin lymphoma
Evans, LS
Hancock, BW
LANCET, 2003, 362 (9378): : 139 - 146
[36] Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma
Spasevska, Ivana
Josefsson, Sarah
Blaker, Yngvild Nuvin
Steen, Chloe B.
Sharma, Ankush
Kushekhar, Kushi
Meyer, Saskia
Kolstad, Arne
Beiske, Klaus
Holte, Harald
Ostenstad, Bjorn
Kimby, Eva
Olweus, Johanna
Tasken, Kjetil
Lorenz, Suzanne
Smeland, Erlend B.
Alizadeh, Ash A.
Huse, Kanutte
Myklebust, June Helen
BLOOD, 2020, 136
[37] The Impact of Pre-Existing Autoimmune Disease on the Safety and Efficacy of CAR T-Cell Therapy for Non-Hodgkin Lymphoma
Gaulin, Charles
Alotaibi, Shaykhah
Bansal, Radhika
Huff, Daniel
Iqbal, Madiha
Wang, Yucai
Cartagena, Julio
Moustafa, Muhamad Alhaj
Rosenthal, Allison C.
Khurana, Arushi
Murthy, Hemant S.
Tsang, Mazie
Maurer, Matthew J.
Hilal, Talal
Johnston, Patrick B.
Paludo, Jonas
Palmer, Jeanne
Villasboas, Jose. C.
Ansell, Stephen M.
Nowakowski, Grzegorz S.
Castro, Januario E.
Kharfan-Dabaja, Mohamed A.
Lin, Yi
Munoz, Javier L.
BLOOD, 2023, 142
[38] Characteristics of Patients with Relapsed/Refractory Burkitt Non-Hodgkin Lymphoma (NHL): Impact on the Feasibility of CAR-T Cell Therapy
Gamero, Sonia Fortin
Lin, Yi
Kenderian, Saad S.
Bennani, N. Nora
Thanarajasingam, Gita
Habermann, Thomas M.
Nowakowski, Grzegorz
Witzig, Thomas E.
BLOOD, 2019, 134
[39] Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan
Arisawa, K
Soda, M
Endo, S
Kurokawa, K
Katamine, S
Shimokawa, I
Koba, T
Takahashi, T
Saito, H
Doi, H
Shirahama, S
INTERNATIONAL JOURNAL OF CANCER, 2000, 85 (03) : 319 - 324
[40] LYMPHOBLASTIC T-CELL NON-HODGKIN LYMPHOMA
Robbens, C.
Vanwyck, R.
JBR-BTR, 2008, 91 (03): : 110 - 111

← 1 2 3 4 5 →